NPPA

Chr 1ADAR

natriuretic peptide A

Also known as: ANF, ANP, ATFB6, ATRST2, CDD, CDD-ANF, CDP, PND

The protein encoded by this gene belongs to the natriuretic peptide family. Natriuretic peptides are implicated in the control of extracellular fluid volume and electrolyte homeostasis. This protein is synthesized as a large precursor (containing a signal peptide), which is processed to release a peptide from the N-terminus with similarity to vasoactive peptide, cardiodilatin, and another peptide from the C-terminus with natriuretic-diuretic activity. Mutations in this gene have been associated with atrial fibrillation familial type 6. This gene is located adjacent to another member of the natriuretic family of peptides on chromosome 1. [provided by RefSeq, Oct 2015]

OMIMResearchGenerating clinical summary…
MultiplemechanismAD/ARLOEUF 1.742 OMIM phenotypes
Clinical SummaryNPPA
🧬
Gene-Disease Validity (ClinGen)
dilated cardiomyopathy · ARNo Known Disease Relationship

No known disease relationship

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
2 unique Pathogenic / Likely Pathogenic· 102 VUS of 188 total submissions
💊
Clinical Trials
3 active or recruiting trials — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.74LOEUF
pLI 0.001
Z-score 0.19
OE 0.91 (0.471.74)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-0.27Z-score
OE missense 1.08 (0.921.27)
100 obs / 92.8 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.91 (0.471.74)
00.351.4
Missense OE?1.08 (0.921.27)
00.61.4
Synonymous OE?1.13
01.21.6
LoF obs/exp: 5 / 5.5Missense obs/exp: 100 / 92.8Syn Z: -0.63

This gene — mechanism propensity

DN
0.84top 10%
GOF
0.6737th %ile
LOF
0.1993th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). The Badonyi & Marsh model scores dominant-negative highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports gain-of-function. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median · 1 literature citation
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

GOFNPPA Gain-of-Function Mutation Associated with Familial Atrial Fibrillation1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 19646991

ClinVar Variant Classifications

188 submitted variants in ClinVar

Classification Summary

Pathogenic1
Likely Pathogenic1
VUS102
Likely Benign60
Benign19
Conflicting3
1
Pathogenic
1
Likely Pathogenic
102
VUS
60
Likely Benign
19
Benign
3
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
0
0
0
1
Likely Pathogenic
1
0
0
0
1
VUS
5
91
4
2
102
Likely Benign
0
6
18
36
60
Benign
1
1
17
0
19
Conflicting
3
Total8983938186

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

39 pathogenic / likely-pathogenic (of 58) ClinVar copy-number / structural variants overlap NPPA — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

NPPA · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.